Navigation Links
Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
Date:7/25/2011

CINCINNATI, July 25, 2011 /PRNewswire/ -- Prasco Laboratories, the Authorized Generics company, announced today it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Mefenamic Acid Capsules, USP 250 mg, the Authorized Generic version of Ponstel®. Prasco intends to begin shipping product immediately in the U.S. under the Prasco label.

"With the introduction of the authorized generic of Shionogi's PONSTEL®, Prasco continues to be the preferred partner for established brand companies to transcend their brands with our Authorized Generics," said Prasco Chief Executive Officer E. Thomas Arington. "We are pleased to have established this relationship with Shionogi Inc., a company that has been providing innovative medicines essential to people's health."

Prasco is the leading Authorized Generics company having brought more Authorized Generics to market than any other company. Prasco Authorized Generics are identical to the NDA brand product. Prasco partners with established brand companies to bring their products to the generics marketplace as Authorized Generics, which offers alternatives for consumers and pharmacists.

Mefenamic Acid Capsules are AB-rated, therapeutically equivalent and substitutable for the brand Ponstel. For additional important information, please click here to see the Full Prescribing Information, INCLUDING BOXED WARNING.

Ponstel® is a registered trademark of Shionogi Inc.

About Prasco Laboratories

Prasco is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Gen
'/>"/>

SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ( ... announced today that it has completed integration with ... for Plastic Surgery and Dermatology practices. ... value to healthcare practices using Nextech," stated ... Corporation. "Using information from the EMR we are ...
(Date:8/21/2014)... /CNW/ - Eisai Limited is pleased to support the Canadian ... book available in Canada . The comic ... educate children and their parents about epilepsy, the most common ... than 300,000 Canadians. Eisai is guided by a corporate philosophy ... the patient is central – there was a need within ...
(Date:8/21/2014)... /PRNewswire-iReach/ -- Inc. magazine today ranked ... straight year, No. 349 in Health on its ... the nation,s fastest-growing private companies. The list represents ... segment of the economy—America,s independent entrepreneurs. Companies such ... Zillow, and many other well-known names gained early ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... DIEGO, Jan. 10, 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: ... Linda Amper, Ph.D., as Senior Vice President of Human ... Economics & Outcomes Research (HEOR), and John Womelsdorf, Ph.D., ... will strengthen the management team as the Company prepares ...
... Calif., Jan. 10, 2011 OncoMed Pharmaceuticals, Inc., ... today announced that patient dosing has commenced in a Phase ... tumor cancers.   OMP-59R5 is a monoclonal antibody ... to specifically block these targets to enter human studies.  The ...
Cached Medicine Technology:Optimer Pharmaceuticals Announces Key Additions to Management Team 2Optimer Pharmaceuticals Announces Key Additions to Management Team 3Optimer Pharmaceuticals Announces Key Additions to Management Team 4OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 2OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 3
(Date:8/22/2014)... patients who need surgery for facial pain caused by ... often used, reports a study in the September issue ... the Congress of Neurological Surgeons . The journal ... a part of Wolters Kluwer Health . , ... much lower cost than other types of surgical treatments ...
(Date:8/22/2014)... August 22, 2014 “Dr. Luciana Show – ... , aka Dr. Luciana, is finding it challenging to stay ... while taking care of hundreds of students, so the editing ... the show is completed, and she recently entered it into ... including those of her husband, actor/screenwriter Gregory Graham , ...
(Date:8/22/2014)... 22, 2014 The report "Higher ... Security & Compliance, Campus Technology, Student & Curriculum, ... (2014-2019)", defines and segments the global Higher Ed ... and forecasting of market sizes. The report also ... and opportunities impacting it along with the adoption ...
(Date:8/22/2014)... However, these are two entirely different mechanisms that occur ... digest lactose properly because they lack an enzyme known ... more dangerous cow milk allergy, however, the body,s immune ... , According to statistics, about two to three percent ... allergy. Less adults are diagnosed with the disease. The ...
(Date:8/22/2014)... August 22, 2014 This funding was ... research affiliate, Saneron CCEL Therapeutics, Inc. in the form ... is extremely pleased to collaborate with Saneron on several ... we hope will lead to regenerative therapies using ... as ALS,” David Portnoy, Chairman and Co-CEO of Cryo-Cell, ...
Breaking Medicine News(10 mins):Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Scientists uncover why major cow milk allergen is actually allergenic 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 3
... psoriasis condition are more likely to smoke, and smoking contributes ... scaling of the skin, and affect places like legs, scalp, ... of the feet. The chances of people with psoriasis suffering ... published in the Archives of Dermatology. ,Data ...
... Co, known as MSD India, has entered into a collaboration ... studies on the former's investigational cervical cancer drug, Gardasil.// ... India. Under the agreement, clinical trials will be conducted for ... ,The vaccine that has been developed by Merck and ...
... Rutgers, The State University of New Jersey have come ... related to determining the quality of mate in humans.// ... in choosing mates among many animal species. Impressive dancers ... ,Rutgers in association with computer scientist at the University ...
... sitting or lying down is a treatable health problem, but ... ,The condition, called Restless Legs Syndrome (RLS), makes it ... long drives or even while watching a movie, say experts., ... which is accompanied in many cases by a tingling and ...
... Department of Health and Mental Hygiene (DOHMH) has banned at ... "dangerous levels" of lead and mercury. // , ,"Though ... Board of the Institute of Medicine of the National Academies ... ppm (parts per million) of lead and no more than ...
... we took note and took care of mother nature. ... USA.,It is called the Canon National Parks Science Scholars ... eight doctoral students -- from Canada to Chile, and ... are receiving significant multi-year scholarships this year to conduct ...
Cached Medicine News:Health News:Merck, ICMR to conduct joint trials on cervical cancer vaccine 2Health News:Shaking Legs Syndrome Is Curable 2Health News:NY Health Dept Bans 3 Ayurveda Drugs 2Health News:Time to wake up as conservationists 2Health News:Time to wake up as conservationists 3
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
Angled 45 degrees, 10 mm shaft with 0.2 mm tip. Round knurled handle with dull finish. Overall length: 4.6 inches....
Straight 31 mm shaft with flat handle and polished finish. 0.5 mm cup. Overall length: 5 inches....
0.5 mm curette cup, reverse side of sandblasted to polish capsule. Round knurled handle with polished finish. Overall length: 5 inches....
Medicine Products: